Niagen Bioscience, Inc. (NAGE) — Capital Reinvestment Ratio
Latest as of September 2025:
0.01x
Niagen Bioscience, Inc. (NAGE) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($3.69 Million) in capital expenditures ($24.00K). See free cash flow generation of Niagen Bioscience, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$3.69 Million
USD
Capital Expenditures
$24.00K
USD
Data as of
Sep 2025
Most recent filing
Niagen Bioscience, Inc. Capital Reinvestment Ratio (2023–2024)
This chart tracks Niagen Bioscience, Inc.'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Niagen Bioscience, Inc. (2023–2024)
Year-by-year Capital Reinvestment Ratio for Niagen Bioscience, Inc. from 2023 to 2024. For live market cap and broader valuation context, see how much is Niagen Bioscience, Inc. worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $12.11 Million | $163.00K | ▼ -35.3% |
| 2023 | 0.02x | $7.12 Million | $148.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow